Author name: groggles

In a study just published by the British Journal of Urology International, the association between nerve-sparing radical prostatectomy and the risk of increased margins – that is, edges of the removed tumour that show cancer cells – is assessed. Looking at a large cohort of patients who underwent nerve-sparing radical prostatectomy, Dr Moore – a […]

In research recently accepted for publication in the British Journal of Urology International, Dr Stricker – as part of a team of Australian health professionals at the Garvan Institute of Medical Research and St Vincents Prostate Cancer Centre – looked at the way in which the type of cancer at the edges of a removed

St Vincent’s Prostate Cancer Centre, as Chaired by Dr Phillip Stricker, is one of five international sites to engage in a study to assess the pentafecta. The pentafecta is a new concept used to report outcomes of minimally invasive robotic surgery and was championed by Vip Patel. Traditionally surgeons viewed robotic surgery outcomes in terms

Safe and accurate biopsies are essential to the management of prostate cancer. Whilst the transrectal biopsy is more common in Australia, transperineal biopsy potentially has a lower risk of infection rate and better detection of anterior-based tumours. As a leader in the care of men with prostate cancer and a world initiator of the transperineal

Reporter Natasha Johnson’s story, ‘Prostate surgery under the microscope’, looks at the use of robotic surgery in prostate cancer and the research that compares it to traditional open surgery. Leading prostate specialists give their views.

Set to expand the wealth of knowledge and further pioneer the care and treatment of men with prostate cancer, Dr Stricker is this year engaging in a new clinical trial. Having commenced in early 2012 the trial focuses on low risk prostate cancers and the role of Magnetic Resonance Imaging (MRI). Open to all men

Dr Stricker is recognised by Device Technologies for having performed over 700 robotic surgeries. He is presented with the ‘Club 700‘ certificate by Peter Ord of Device Technologies Australia.

On the 3 November 2011 Dr Phillip Stricker completed his 700th robotic case. Dr Stricker’s robotic results show a 96.5% clearance rate in the eradication of early stage prostate cancer and 86% clearance rate in overall cancers. Click here for more on Dr Stricker’s robotic surgery results.

Dr Stricker has commenced a new form of laser therapy for benign prostatic hyperplasia using the biolitic laser technology. This is the first time this has been used in Australia and Dr Stricker is initially performing a trial at St Vincent’s. Preliminary results are excellent with patients being discharged within 24 hours and often within

The Treasurer, the Hon. Wayne Swan launched the prostate cancer DVD “So How Do You Choose” at a function at Parliament House Canberra in May 2009. The DVD was produced by Doctor Phillip Stricker and the St Vincent’s Prostate Cancer Centre through the financial support of Lang & Sue Walker and the Walker Foundation. The

Recently Dr Stricker delivered a series of lectures at Cornell University at the Inaugural International Prostate Cancer and Advanced Robotic Techniques Symposium in New York. Speaking on multimodal therapy for locally advance prostate cancer and also on robotic surgery versus laparoscopic and open surgery, Dr Stricker was one of 71 world experts invited to present

Dr James Symons, Fellow at the St Vincent’s Prostate Cancer Centre, presented the results of the quality of life follow up on patients treated by Dr Stricker since 2006. Attended by more than 20,000 delegates the results of open and robotic radical prostatectomy were presented at the Annual Urological Association meeting in Washington.